HEALTH

PITTSBURGH — Mylan and Biocon have a deal to develop and sell generic insulin-analog products for diabetes, Mylan said.

Under the deal, Mylan will have the rights to develop and market Biocon's Glargine, Lispro and Aspart, respectively generic versions of Sanofi's Lantus, Eli Lilly's Humalog and Novo Nordisk's NovoLog.

NORTHRIDGE, Calif. — Pharmavite on Tuesday announced that its Voots Veggie-Fruit Tarts brand, a fruit- and vegetable-based supplement for kids ages 4 years and older, are now available for purchase at Walgreens locations nationwide.

NEW YORK — The YMCA is sponsoring a diabetes-control program that some say could slow the disease's spread, according to published reports.

HYDERABAD, India — The Food and Drug Administration has approved a generic diabetes drug made by Aurobindo Pharma, the drug maker said.

Aurobindo announced the approval of pioglitazone tablets in the 15 mg, 30 mg and 45 mg strengths, in addition to the earlier tentative approval it received for pioglitazone and metformin hydrochloride tablets in the 15 mg/500 mg and 15 mg/850 mg strengths.

BOSTON — According to research published Thursday in the New England Journal of Medicine, not all respiratory ailments that generate influenza-like symptoms can be attributed to the flu. The human metapneumovirus — which is not a strain of influenza, is impervious to antiviral medicines like Tamiflu and does not have an available vaccine according to reports — causes just as many hospitalizations and outpatient visits among children as does the flu. 

SILVER SPRING, Md. — U.S. marshals, acting on behalf of the Food and Drug Administration, on Thursday seized tainted products from Globe All Wellness in Hollywood, Fla. The products may be unsafe because they contain an undisclosed active pharmaceutical ingredient.

PITTSBURGH — GNC on Friday announced that its employees and customers donated a total of $3.1 million over the past few months to support the St. Jude Children's Research Hospital Thanks and Giving campaign. The campaign, now in its ninth year, builds awareness of and raises funds for the research and treatment done at St. Jude to help children fighting cancer.